Jonathan C. Fox - 02 Mar 2023 Form 3 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
Director
Signature
/s/ John R. Moore, Attorney-in-Fact for Fox Jonathan C
Issuer symbol
EWTX
Transactions as of
02 Mar 2023
Net transactions value
$0
Form type
3
Filing time
07 Mar 2023, 16:57:37 UTC
Next filing
07 Mar 2023

No securities are beneficially owned.